O Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
Sjedište251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Osnovano2018
StatusAktivno

Patenti1 patent

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

Pretraži sve patente na Heelky →

Recenzije

Još nema recenzija. Surađivali ste s Assertio Therapeutics, Inc.? Budite prvi koji će podijeliti iskustvo.

Napišite recenziju →

Kontakt i poveznice

Lokacija

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

Je li ovo vaša tvrtka?

Besplatno preuzmite ovu stranicu da dodate logotip, proizvode, fotografije i poslove te da odgovarate na recenzije.

Preuzmite ovu stranicu

Podijelite ovu tvrtku

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

Kopiraj poveznicu

Podijeli na

QR kod

Skenirajte ga kamerom telefona da biste otvorili ovu stranicu, ili ga preuzmite za letak, slajd ili značku.

Pridružite se Heelky da se povežete, zapošljavate i rastete

Stvorite besplatan račun da biste slali poruke, prijavljivali se na poslove i objavljivali misije.

Pridruži se — besplatno je

Odaberite svoj jezik

Heelky će zapamtiti vaš odabir.

Ostali jezici

Dostupni jezici: 70 O jezicima na Heelky